TINO, JOSEPH A.,SRIVASTAVA, ANURAG S.,KO, SOO SUNG,GALELLA, MICHAEL A.,LANGEVINE, CHARLES M.,DELUCCA, GEORGE V.,LIU, QINGJIE,BATT, DOUGLAS G.,WATTERSON, SCOTT HUNTER,SHI, QING,BERTRAND, MYRA BEAUDOIN
申请号：
PH12015502630
公开号：
PH12015502630A1
申请日:
2015.11.26
申请国别(地区):
PH
年份:
2016
代理人:
摘要：
Disclosed are compounds of Formula (I) wherein: the two dotted lines represent either two single or two double bonds； Q is: R1 is F, Cl, CN, or CH3； R2 is Cl or CH3； R3 is C(CH3)2OH or CH2CH2OH； Ra is H or CH3； each R6 is independently F, Cl, CH3, and/or OCH3； and n is zero, 1, or 2. Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
